Brain Canada recently announced that it is providing over $10.5M in funding spread across four platforms focused on neurological disease, mental illness, and childhood brain conditions. The WONDER platform, co-led by University of Calgary researcher Dr Paul Arnold, will use part of this funding to support personalized approaches to care for children with conditions like autism, ADHD, and cerebral palsy. University of Toronto researchers will continue their research on epilepsy and Parkinson’s disease through the Centre for Neurotechnological Innovation to Application (CRANIA). Data from CRANIA will be shared with hospital networks and researchers from universities including Dalhousie University. Funding for Canada’s National Ultra-High Field MRI Platform, located at Western University, will be used to support operations and to maintain the platform’s open-science framework.
